Pfizer Animal Health acquires two market-leading
livestock genomics companies.
Pfizer Animal Health acquires two market-leading livestock genomics
companies:
* Catapult Genetics, Pty., Ltd., focused on developing and
commercializing innovative livestock DNA tests and gene markers to
assist global food producers, processors and retailers in improving
profitability and quality in the global food chain; and
* Bovigen, LLC, which markets DNA technology, including
Catapult's products in the U.S. and throughout Canada, Central
America and South America.
"This is a strategic initiative that places Pfizer at the
forefront of livestock gene marker R&D and enhances Pfizer's
ability to offer more complete solutions to global livestock
producers," says Pfizer Animal Health Pres. Juan Ramon Alaix.
COPYRIGHT 2008 Doane Information
Service Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2008 Gale, Cengage Learning. All rights
reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.